CLINICAL ENDOCRINOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=973184, encodeId=b8739e3184bd, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：临床;内分泌 经验分享：2021-6-2号投稿 2021-6-13变成了Awaiting Decision，两周不到，这个速度是有点快，同时伴随一种不祥的预感，下周一应该能看到Decision吧，到时候再来更新，祝福我自己 --.--, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5d45263398, createdName=Q.Aur., createdTime=Sun Jun 13 00:06:23 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559798, encodeId=50cf559e9840, content=Under review 下一个是什么大概多久呀151****6521暂无昵称 2018-06-04 发表:: 投稿第二天就Under review了，听说这个杂志没有with editor这个状态151****6521暂无昵称 2018-06-04 13:56:00 发表: 投稿第二天就Under review了，听说这个杂志没有with editor这个状态, beContent=151****6521暂无昵称 2018-06-04 发表:: 投稿第二天就Under review了，听说这个杂志没有with editor这个状态, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e2398662, createdName=1234c804m77暂无昵称, createdTime=Fri Aug 03 00:00:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051656, encodeId=2a5010516561e, content=Awaiting decision一周了还没有消息，煎熬………, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200909/95b4974e88e842ffbad908960e8dd61c/ff296ee52f2547ddb4e28540d5a3eb41.jpg, createdBy=00745416786, createdName=ms1000000363315575, createdTime=Wed Sep 15 22:45:18 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115113, encodeId=ceb92115113fa, content=投稿两个多月了，现在还是Under Review，催了一次编辑说是还在找审稿人，审稿有点慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210810/2b20a1e314924e5396c0110729210109/544383ced8934545a4b92896a7ffeef1.jpg, createdBy=b6715568846, createdName=Iam雨后彩虹, createdTime=Fri Feb 17 16:10:56 CST 2023, time=2023-02-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1179873, encodeId=1f3611e9873a8, content=请问一下各位大佬，该杂志需要版面费吗，case report and review接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ca66444402, createdName=ms5000001652603950, createdTime=Sun Jan 02 22:47:21 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501260, encodeId=93da50126070, content=请问楼下的这个杂志在线投稿时，第4项是推荐reviewer，而且还是必须要填的，不然无法成功投稿，从哪里能找到他们的reviewer啊？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=440, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Feb 21 23:01:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052346, encodeId=4b6c10523465b, content=偏重的研究方向：内分泌 经验分享：2021.09.16投稿，2021.09.17让修稿，但是审稿意见就说了下如果是随机对照实验的话，请遵循对照原则（我的不是），然后提了下文章格式让弄成双倍间隔，就没有了。感觉好危险，这怎么修啊，你们的会给你发修改稿吗，上面会标注细节的那种？第一次投稿的小白，希望同道回答下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaec5572087, createdName=ms9000001057878125, createdTime=Fri Sep 17 16:29:14 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210105, encodeId=f67c12101054d, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：内分泌 经验分享：不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e29b1939503, createdName=Wittyone, createdTime=Sun Apr 10 19:28:15 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581170, encodeId=a8b45811e0f9, content=都说不收糖尿病的了hpchensd 2019-11-21 00:00:00 发表: 啥原因？我也想投一篇糖尿病高血压的, beContent=hpchensd 2019-11-21 00:00:00 发表: 啥原因？我也想投一篇糖尿病高血压的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/01/768c3273b4a500f3bc36c611fc31585d.jpg, createdBy=3f032574018, createdName=Allianst, createdTime=Mon Dec 09 00:00:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198382, encodeId=8573119838230, content=这杂志对国人友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc31688675, createdName=Labmed 9954, createdTime=Tue Mar 01 15:16:11 CST 2022, time=2022-03-01, status=1, ipAttribution=)]

2021-06-13 Q.Aur.

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：临床;内分泌
经验分享：2021-6-2号投稿 2021-6-13变成了Awaiting Decision，两周不到，这个速度是有点快，同时伴随一种不祥的预感，下周一应该能看到Decision吧，到时候再来更新，祝福我自己 --.--

76 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=973184, encodeId=b8739e3184bd, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：临床;内分泌 经验分享：2021-6-2号投稿 2021-6-13变成了Awaiting Decision，两周不到，这个速度是有点快，同时伴随一种不祥的预感，下周一应该能看到Decision吧，到时候再来更新，祝福我自己 --.--, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5d45263398, createdName=Q.Aur., createdTime=Sun Jun 13 00:06:23 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559798, encodeId=50cf559e9840, content=Under review 下一个是什么大概多久呀151****6521暂无昵称 2018-06-04 发表:: 投稿第二天就Under review了，听说这个杂志没有with editor这个状态151****6521暂无昵称 2018-06-04 13:56:00 发表: 投稿第二天就Under review了，听说这个杂志没有with editor这个状态, beContent=151****6521暂无昵称 2018-06-04 发表:: 投稿第二天就Under review了，听说这个杂志没有with editor这个状态, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e2398662, createdName=1234c804m77暂无昵称, createdTime=Fri Aug 03 00:00:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051656, encodeId=2a5010516561e, content=Awaiting decision一周了还没有消息，煎熬………, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200909/95b4974e88e842ffbad908960e8dd61c/ff296ee52f2547ddb4e28540d5a3eb41.jpg, createdBy=00745416786, createdName=ms1000000363315575, createdTime=Wed Sep 15 22:45:18 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115113, encodeId=ceb92115113fa, content=投稿两个多月了，现在还是Under Review，催了一次编辑说是还在找审稿人，审稿有点慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210810/2b20a1e314924e5396c0110729210109/544383ced8934545a4b92896a7ffeef1.jpg, createdBy=b6715568846, createdName=Iam雨后彩虹, createdTime=Fri Feb 17 16:10:56 CST 2023, time=2023-02-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1179873, encodeId=1f3611e9873a8, content=请问一下各位大佬，该杂志需要版面费吗，case report and review接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ca66444402, createdName=ms5000001652603950, createdTime=Sun Jan 02 22:47:21 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501260, encodeId=93da50126070, content=请问楼下的这个杂志在线投稿时，第4项是推荐reviewer，而且还是必须要填的，不然无法成功投稿，从哪里能找到他们的reviewer啊？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=440, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Feb 21 23:01:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052346, encodeId=4b6c10523465b, content=偏重的研究方向：内分泌 经验分享：2021.09.16投稿，2021.09.17让修稿，但是审稿意见就说了下如果是随机对照实验的话，请遵循对照原则（我的不是），然后提了下文章格式让弄成双倍间隔，就没有了。感觉好危险，这怎么修啊，你们的会给你发修改稿吗，上面会标注细节的那种？第一次投稿的小白，希望同道回答下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaec5572087, createdName=ms9000001057878125, createdTime=Fri Sep 17 16:29:14 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210105, encodeId=f67c12101054d, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：内分泌 经验分享：不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e29b1939503, createdName=Wittyone, createdTime=Sun Apr 10 19:28:15 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581170, encodeId=a8b45811e0f9, content=都说不收糖尿病的了hpchensd 2019-11-21 00:00:00 发表: 啥原因？我也想投一篇糖尿病高血压的, beContent=hpchensd 2019-11-21 00:00:00 发表: 啥原因？我也想投一篇糖尿病高血压的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/01/768c3273b4a500f3bc36c611fc31585d.jpg, createdBy=3f032574018, createdName=Allianst, createdTime=Mon Dec 09 00:00:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198382, encodeId=8573119838230, content=这杂志对国人友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc31688675, createdName=Labmed 9954, createdTime=Tue Mar 01 15:16:11 CST 2022, time=2022-03-01, status=1, ipAttribution=)]

2018-08-03 1234c804m77暂无昵称

Under review 下一个是什么大概多久呀151****6521暂无昵称 2018-06-04 发表::
投稿第二天就Under review了，听说这个杂志没有with editor这个状态151****6521暂无昵称 2018-06-04 13:56:00 发表:
投稿第二天就Under review了，听说这个杂志没有with editor这个状态

151****6521暂无昵称 2018-06-04 发表:: 投稿第二天就Under review了，听说这个杂志没有with editor这个状态

363 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=973184, encodeId=b8739e3184bd, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：临床;内分泌 经验分享：2021-6-2号投稿 2021-6-13变成了Awaiting Decision，两周不到，这个速度是有点快，同时伴随一种不祥的预感，下周一应该能看到Decision吧，到时候再来更新，祝福我自己 --.--, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5d45263398, createdName=Q.Aur., createdTime=Sun Jun 13 00:06:23 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559798, encodeId=50cf559e9840, content=Under review 下一个是什么大概多久呀151****6521暂无昵称 2018-06-04 发表:: 投稿第二天就Under review了，听说这个杂志没有with editor这个状态151****6521暂无昵称 2018-06-04 13:56:00 发表: 投稿第二天就Under review了，听说这个杂志没有with editor这个状态, beContent=151****6521暂无昵称 2018-06-04 发表:: 投稿第二天就Under review了，听说这个杂志没有with editor这个状态, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e2398662, createdName=1234c804m77暂无昵称, createdTime=Fri Aug 03 00:00:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051656, encodeId=2a5010516561e, content=Awaiting decision一周了还没有消息，煎熬………, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200909/95b4974e88e842ffbad908960e8dd61c/ff296ee52f2547ddb4e28540d5a3eb41.jpg, createdBy=00745416786, createdName=ms1000000363315575, createdTime=Wed Sep 15 22:45:18 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115113, encodeId=ceb92115113fa, content=投稿两个多月了，现在还是Under Review，催了一次编辑说是还在找审稿人，审稿有点慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210810/2b20a1e314924e5396c0110729210109/544383ced8934545a4b92896a7ffeef1.jpg, createdBy=b6715568846, createdName=Iam雨后彩虹, createdTime=Fri Feb 17 16:10:56 CST 2023, time=2023-02-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1179873, encodeId=1f3611e9873a8, content=请问一下各位大佬，该杂志需要版面费吗，case report and review接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ca66444402, createdName=ms5000001652603950, createdTime=Sun Jan 02 22:47:21 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501260, encodeId=93da50126070, content=请问楼下的这个杂志在线投稿时，第4项是推荐reviewer，而且还是必须要填的，不然无法成功投稿，从哪里能找到他们的reviewer啊？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=440, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Feb 21 23:01:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052346, encodeId=4b6c10523465b, content=偏重的研究方向：内分泌 经验分享：2021.09.16投稿，2021.09.17让修稿，但是审稿意见就说了下如果是随机对照实验的话，请遵循对照原则（我的不是），然后提了下文章格式让弄成双倍间隔，就没有了。感觉好危险，这怎么修啊，你们的会给你发修改稿吗，上面会标注细节的那种？第一次投稿的小白，希望同道回答下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaec5572087, createdName=ms9000001057878125, createdTime=Fri Sep 17 16:29:14 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210105, encodeId=f67c12101054d, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：内分泌 经验分享：不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e29b1939503, createdName=Wittyone, createdTime=Sun Apr 10 19:28:15 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581170, encodeId=a8b45811e0f9, content=都说不收糖尿病的了hpchensd 2019-11-21 00:00:00 发表: 啥原因？我也想投一篇糖尿病高血压的, beContent=hpchensd 2019-11-21 00:00:00 发表: 啥原因？我也想投一篇糖尿病高血压的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/01/768c3273b4a500f3bc36c611fc31585d.jpg, createdBy=3f032574018, createdName=Allianst, createdTime=Mon Dec 09 00:00:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198382, encodeId=8573119838230, content=这杂志对国人友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc31688675, createdName=Labmed 9954, createdTime=Tue Mar 01 15:16:11 CST 2022, time=2022-03-01, status=1, ipAttribution=)]

2021-09-15 ms1000000363315575

Awaiting decision一周了还没有消息，煎熬………

64 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=973184, encodeId=b8739e3184bd, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：临床;内分泌 经验分享：2021-6-2号投稿 2021-6-13变成了Awaiting Decision，两周不到，这个速度是有点快，同时伴随一种不祥的预感，下周一应该能看到Decision吧，到时候再来更新，祝福我自己 --.--, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5d45263398, createdName=Q.Aur., createdTime=Sun Jun 13 00:06:23 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559798, encodeId=50cf559e9840, content=Under review 下一个是什么大概多久呀151****6521暂无昵称 2018-06-04 发表:: 投稿第二天就Under review了，听说这个杂志没有with editor这个状态151****6521暂无昵称 2018-06-04 13:56:00 发表: 投稿第二天就Under review了，听说这个杂志没有with editor这个状态, beContent=151****6521暂无昵称 2018-06-04 发表:: 投稿第二天就Under review了，听说这个杂志没有with editor这个状态, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e2398662, createdName=1234c804m77暂无昵称, createdTime=Fri Aug 03 00:00:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051656, encodeId=2a5010516561e, content=Awaiting decision一周了还没有消息，煎熬………, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200909/95b4974e88e842ffbad908960e8dd61c/ff296ee52f2547ddb4e28540d5a3eb41.jpg, createdBy=00745416786, createdName=ms1000000363315575, createdTime=Wed Sep 15 22:45:18 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115113, encodeId=ceb92115113fa, content=投稿两个多月了，现在还是Under Review，催了一次编辑说是还在找审稿人，审稿有点慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210810/2b20a1e314924e5396c0110729210109/544383ced8934545a4b92896a7ffeef1.jpg, createdBy=b6715568846, createdName=Iam雨后彩虹, createdTime=Fri Feb 17 16:10:56 CST 2023, time=2023-02-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1179873, encodeId=1f3611e9873a8, content=请问一下各位大佬，该杂志需要版面费吗，case report and review接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ca66444402, createdName=ms5000001652603950, createdTime=Sun Jan 02 22:47:21 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501260, encodeId=93da50126070, content=请问楼下的这个杂志在线投稿时，第4项是推荐reviewer，而且还是必须要填的，不然无法成功投稿，从哪里能找到他们的reviewer啊？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=440, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Feb 21 23:01:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052346, encodeId=4b6c10523465b, content=偏重的研究方向：内分泌 经验分享：2021.09.16投稿，2021.09.17让修稿，但是审稿意见就说了下如果是随机对照实验的话，请遵循对照原则（我的不是），然后提了下文章格式让弄成双倍间隔，就没有了。感觉好危险，这怎么修啊，你们的会给你发修改稿吗，上面会标注细节的那种？第一次投稿的小白，希望同道回答下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaec5572087, createdName=ms9000001057878125, createdTime=Fri Sep 17 16:29:14 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210105, encodeId=f67c12101054d, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：内分泌 经验分享：不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e29b1939503, createdName=Wittyone, createdTime=Sun Apr 10 19:28:15 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581170, encodeId=a8b45811e0f9, content=都说不收糖尿病的了hpchensd 2019-11-21 00:00:00 发表: 啥原因？我也想投一篇糖尿病高血压的, beContent=hpchensd 2019-11-21 00:00:00 发表: 啥原因？我也想投一篇糖尿病高血压的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/01/768c3273b4a500f3bc36c611fc31585d.jpg, createdBy=3f032574018, createdName=Allianst, createdTime=Mon Dec 09 00:00:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198382, encodeId=8573119838230, content=这杂志对国人友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc31688675, createdName=Labmed 9954, createdTime=Tue Mar 01 15:16:11 CST 2022, time=2022-03-01, status=1, ipAttribution=)]

2023-02-17 Iam雨后彩虹来自上海

投稿两个多月了，现在还是Under Review，催了一次编辑说是还在找审稿人，审稿有点慢啊……

43 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=973184, encodeId=b8739e3184bd, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：临床;内分泌 经验分享：2021-6-2号投稿 2021-6-13变成了Awaiting Decision，两周不到，这个速度是有点快，同时伴随一种不祥的预感，下周一应该能看到Decision吧，到时候再来更新，祝福我自己 --.--, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5d45263398, createdName=Q.Aur., createdTime=Sun Jun 13 00:06:23 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559798, encodeId=50cf559e9840, content=Under review 下一个是什么大概多久呀151****6521暂无昵称 2018-06-04 发表:: 投稿第二天就Under review了，听说这个杂志没有with editor这个状态151****6521暂无昵称 2018-06-04 13:56:00 发表: 投稿第二天就Under review了，听说这个杂志没有with editor这个状态, beContent=151****6521暂无昵称 2018-06-04 发表:: 投稿第二天就Under review了，听说这个杂志没有with editor这个状态, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e2398662, createdName=1234c804m77暂无昵称, createdTime=Fri Aug 03 00:00:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051656, encodeId=2a5010516561e, content=Awaiting decision一周了还没有消息，煎熬………, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200909/95b4974e88e842ffbad908960e8dd61c/ff296ee52f2547ddb4e28540d5a3eb41.jpg, createdBy=00745416786, createdName=ms1000000363315575, createdTime=Wed Sep 15 22:45:18 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115113, encodeId=ceb92115113fa, content=投稿两个多月了，现在还是Under Review，催了一次编辑说是还在找审稿人，审稿有点慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210810/2b20a1e314924e5396c0110729210109/544383ced8934545a4b92896a7ffeef1.jpg, createdBy=b6715568846, createdName=Iam雨后彩虹, createdTime=Fri Feb 17 16:10:56 CST 2023, time=2023-02-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1179873, encodeId=1f3611e9873a8, content=请问一下各位大佬，该杂志需要版面费吗，case report and review接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ca66444402, createdName=ms5000001652603950, createdTime=Sun Jan 02 22:47:21 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501260, encodeId=93da50126070, content=请问楼下的这个杂志在线投稿时，第4项是推荐reviewer，而且还是必须要填的，不然无法成功投稿，从哪里能找到他们的reviewer啊？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=440, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Feb 21 23:01:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052346, encodeId=4b6c10523465b, content=偏重的研究方向：内分泌 经验分享：2021.09.16投稿，2021.09.17让修稿，但是审稿意见就说了下如果是随机对照实验的话，请遵循对照原则（我的不是），然后提了下文章格式让弄成双倍间隔，就没有了。感觉好危险，这怎么修啊，你们的会给你发修改稿吗，上面会标注细节的那种？第一次投稿的小白，希望同道回答下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaec5572087, createdName=ms9000001057878125, createdTime=Fri Sep 17 16:29:14 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210105, encodeId=f67c12101054d, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：内分泌 经验分享：不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e29b1939503, createdName=Wittyone, createdTime=Sun Apr 10 19:28:15 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581170, encodeId=a8b45811e0f9, content=都说不收糖尿病的了hpchensd 2019-11-21 00:00:00 发表: 啥原因？我也想投一篇糖尿病高血压的, beContent=hpchensd 2019-11-21 00:00:00 发表: 啥原因？我也想投一篇糖尿病高血压的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/01/768c3273b4a500f3bc36c611fc31585d.jpg, createdBy=3f032574018, createdName=Allianst, createdTime=Mon Dec 09 00:00:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198382, encodeId=8573119838230, content=这杂志对国人友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc31688675, createdName=Labmed 9954, createdTime=Tue Mar 01 15:16:11 CST 2022, time=2022-03-01, status=1, ipAttribution=)]

2022-01-02 ms5000001652603950

请问一下各位大佬，该杂志需要版面费吗，case report and review接收吗

67 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=973184, encodeId=b8739e3184bd, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：临床;内分泌 经验分享：2021-6-2号投稿 2021-6-13变成了Awaiting Decision，两周不到，这个速度是有点快，同时伴随一种不祥的预感，下周一应该能看到Decision吧，到时候再来更新，祝福我自己 --.--, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5d45263398, createdName=Q.Aur., createdTime=Sun Jun 13 00:06:23 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559798, encodeId=50cf559e9840, content=Under review 下一个是什么大概多久呀151****6521暂无昵称 2018-06-04 发表:: 投稿第二天就Under review了，听说这个杂志没有with editor这个状态151****6521暂无昵称 2018-06-04 13:56:00 发表: 投稿第二天就Under review了，听说这个杂志没有with editor这个状态, beContent=151****6521暂无昵称 2018-06-04 发表:: 投稿第二天就Under review了，听说这个杂志没有with editor这个状态, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e2398662, createdName=1234c804m77暂无昵称, createdTime=Fri Aug 03 00:00:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051656, encodeId=2a5010516561e, content=Awaiting decision一周了还没有消息，煎熬………, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200909/95b4974e88e842ffbad908960e8dd61c/ff296ee52f2547ddb4e28540d5a3eb41.jpg, createdBy=00745416786, createdName=ms1000000363315575, createdTime=Wed Sep 15 22:45:18 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115113, encodeId=ceb92115113fa, content=投稿两个多月了，现在还是Under Review，催了一次编辑说是还在找审稿人，审稿有点慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210810/2b20a1e314924e5396c0110729210109/544383ced8934545a4b92896a7ffeef1.jpg, createdBy=b6715568846, createdName=Iam雨后彩虹, createdTime=Fri Feb 17 16:10:56 CST 2023, time=2023-02-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1179873, encodeId=1f3611e9873a8, content=请问一下各位大佬，该杂志需要版面费吗，case report and review接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ca66444402, createdName=ms5000001652603950, createdTime=Sun Jan 02 22:47:21 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501260, encodeId=93da50126070, content=请问楼下的这个杂志在线投稿时，第4项是推荐reviewer，而且还是必须要填的，不然无法成功投稿，从哪里能找到他们的reviewer啊？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=440, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Feb 21 23:01:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052346, encodeId=4b6c10523465b, content=偏重的研究方向：内分泌 经验分享：2021.09.16投稿，2021.09.17让修稿，但是审稿意见就说了下如果是随机对照实验的话，请遵循对照原则（我的不是），然后提了下文章格式让弄成双倍间隔，就没有了。感觉好危险，这怎么修啊，你们的会给你发修改稿吗，上面会标注细节的那种？第一次投稿的小白，希望同道回答下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaec5572087, createdName=ms9000001057878125, createdTime=Fri Sep 17 16:29:14 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210105, encodeId=f67c12101054d, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：内分泌 经验分享：不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e29b1939503, createdName=Wittyone, createdTime=Sun Apr 10 19:28:15 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581170, encodeId=a8b45811e0f9, content=都说不收糖尿病的了hpchensd 2019-11-21 00:00:00 发表: 啥原因？我也想投一篇糖尿病高血压的, beContent=hpchensd 2019-11-21 00:00:00 发表: 啥原因？我也想投一篇糖尿病高血压的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/01/768c3273b4a500f3bc36c611fc31585d.jpg, createdBy=3f032574018, createdName=Allianst, createdTime=Mon Dec 09 00:00:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198382, encodeId=8573119838230, content=这杂志对国人友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc31688675, createdName=Labmed 9954, createdTime=Tue Mar 01 15:16:11 CST 2022, time=2022-03-01, status=1, ipAttribution=)]

2014-02-21 匿名用户

请问楼下的这个杂志在线投稿时，第4项是推荐reviewer，而且还是必须要填的，不然无法成功投稿，从哪里能找到他们的reviewer啊？谢谢

440 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=973184, encodeId=b8739e3184bd, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：临床;内分泌 经验分享：2021-6-2号投稿 2021-6-13变成了Awaiting Decision，两周不到，这个速度是有点快，同时伴随一种不祥的预感，下周一应该能看到Decision吧，到时候再来更新，祝福我自己 --.--, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5d45263398, createdName=Q.Aur., createdTime=Sun Jun 13 00:06:23 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559798, encodeId=50cf559e9840, content=Under review 下一个是什么大概多久呀151****6521暂无昵称 2018-06-04 发表:: 投稿第二天就Under review了，听说这个杂志没有with editor这个状态151****6521暂无昵称 2018-06-04 13:56:00 发表: 投稿第二天就Under review了，听说这个杂志没有with editor这个状态, beContent=151****6521暂无昵称 2018-06-04 发表:: 投稿第二天就Under review了，听说这个杂志没有with editor这个状态, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e2398662, createdName=1234c804m77暂无昵称, createdTime=Fri Aug 03 00:00:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051656, encodeId=2a5010516561e, content=Awaiting decision一周了还没有消息，煎熬………, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200909/95b4974e88e842ffbad908960e8dd61c/ff296ee52f2547ddb4e28540d5a3eb41.jpg, createdBy=00745416786, createdName=ms1000000363315575, createdTime=Wed Sep 15 22:45:18 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115113, encodeId=ceb92115113fa, content=投稿两个多月了，现在还是Under Review，催了一次编辑说是还在找审稿人，审稿有点慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210810/2b20a1e314924e5396c0110729210109/544383ced8934545a4b92896a7ffeef1.jpg, createdBy=b6715568846, createdName=Iam雨后彩虹, createdTime=Fri Feb 17 16:10:56 CST 2023, time=2023-02-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1179873, encodeId=1f3611e9873a8, content=请问一下各位大佬，该杂志需要版面费吗，case report and review接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ca66444402, createdName=ms5000001652603950, createdTime=Sun Jan 02 22:47:21 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501260, encodeId=93da50126070, content=请问楼下的这个杂志在线投稿时，第4项是推荐reviewer，而且还是必须要填的，不然无法成功投稿，从哪里能找到他们的reviewer啊？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=440, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Feb 21 23:01:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052346, encodeId=4b6c10523465b, content=偏重的研究方向：内分泌 经验分享：2021.09.16投稿，2021.09.17让修稿，但是审稿意见就说了下如果是随机对照实验的话，请遵循对照原则（我的不是），然后提了下文章格式让弄成双倍间隔，就没有了。感觉好危险，这怎么修啊，你们的会给你发修改稿吗，上面会标注细节的那种？第一次投稿的小白，希望同道回答下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaec5572087, createdName=ms9000001057878125, createdTime=Fri Sep 17 16:29:14 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210105, encodeId=f67c12101054d, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：内分泌 经验分享：不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e29b1939503, createdName=Wittyone, createdTime=Sun Apr 10 19:28:15 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581170, encodeId=a8b45811e0f9, content=都说不收糖尿病的了hpchensd 2019-11-21 00:00:00 发表: 啥原因？我也想投一篇糖尿病高血压的, beContent=hpchensd 2019-11-21 00:00:00 发表: 啥原因？我也想投一篇糖尿病高血压的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/01/768c3273b4a500f3bc36c611fc31585d.jpg, createdBy=3f032574018, createdName=Allianst, createdTime=Mon Dec 09 00:00:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198382, encodeId=8573119838230, content=这杂志对国人友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc31688675, createdName=Labmed 9954, createdTime=Tue Mar 01 15:16:11 CST 2022, time=2022-03-01, status=1, ipAttribution=)]

2021-09-17 ms9000001057878125

偏重的研究方向：内分泌
经验分享：2021.09.16投稿，2021.09.17让修稿，但是审稿意见就说了下如果是随机对照实验的话，请遵循对照原则（我的不是），然后提了下文章格式让弄成双倍间隔，就没有了。感觉好危险，这怎么修啊，你们的会给你发修改稿吗，上面会标注细节的那种？第一次投稿的小白，希望同道回答下。

79 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=973184, encodeId=b8739e3184bd, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：临床;内分泌 经验分享：2021-6-2号投稿 2021-6-13变成了Awaiting Decision，两周不到，这个速度是有点快，同时伴随一种不祥的预感，下周一应该能看到Decision吧，到时候再来更新，祝福我自己 --.--, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5d45263398, createdName=Q.Aur., createdTime=Sun Jun 13 00:06:23 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559798, encodeId=50cf559e9840, content=Under review 下一个是什么大概多久呀151****6521暂无昵称 2018-06-04 发表:: 投稿第二天就Under review了，听说这个杂志没有with editor这个状态151****6521暂无昵称 2018-06-04 13:56:00 发表: 投稿第二天就Under review了，听说这个杂志没有with editor这个状态, beContent=151****6521暂无昵称 2018-06-04 发表:: 投稿第二天就Under review了，听说这个杂志没有with editor这个状态, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e2398662, createdName=1234c804m77暂无昵称, createdTime=Fri Aug 03 00:00:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051656, encodeId=2a5010516561e, content=Awaiting decision一周了还没有消息，煎熬………, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200909/95b4974e88e842ffbad908960e8dd61c/ff296ee52f2547ddb4e28540d5a3eb41.jpg, createdBy=00745416786, createdName=ms1000000363315575, createdTime=Wed Sep 15 22:45:18 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115113, encodeId=ceb92115113fa, content=投稿两个多月了，现在还是Under Review，催了一次编辑说是还在找审稿人，审稿有点慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210810/2b20a1e314924e5396c0110729210109/544383ced8934545a4b92896a7ffeef1.jpg, createdBy=b6715568846, createdName=Iam雨后彩虹, createdTime=Fri Feb 17 16:10:56 CST 2023, time=2023-02-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1179873, encodeId=1f3611e9873a8, content=请问一下各位大佬，该杂志需要版面费吗，case report and review接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ca66444402, createdName=ms5000001652603950, createdTime=Sun Jan 02 22:47:21 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501260, encodeId=93da50126070, content=请问楼下的这个杂志在线投稿时，第4项是推荐reviewer，而且还是必须要填的，不然无法成功投稿，从哪里能找到他们的reviewer啊？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=440, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Feb 21 23:01:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052346, encodeId=4b6c10523465b, content=偏重的研究方向：内分泌 经验分享：2021.09.16投稿，2021.09.17让修稿，但是审稿意见就说了下如果是随机对照实验的话，请遵循对照原则（我的不是），然后提了下文章格式让弄成双倍间隔，就没有了。感觉好危险，这怎么修啊，你们的会给你发修改稿吗，上面会标注细节的那种？第一次投稿的小白，希望同道回答下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaec5572087, createdName=ms9000001057878125, createdTime=Fri Sep 17 16:29:14 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210105, encodeId=f67c12101054d, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：内分泌 经验分享：不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e29b1939503, createdName=Wittyone, createdTime=Sun Apr 10 19:28:15 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581170, encodeId=a8b45811e0f9, content=都说不收糖尿病的了hpchensd 2019-11-21 00:00:00 发表: 啥原因？我也想投一篇糖尿病高血压的, beContent=hpchensd 2019-11-21 00:00:00 发表: 啥原因？我也想投一篇糖尿病高血压的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/01/768c3273b4a500f3bc36c611fc31585d.jpg, createdBy=3f032574018, createdName=Allianst, createdTime=Mon Dec 09 00:00:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198382, encodeId=8573119838230, content=这杂志对国人友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc31688675, createdName=Labmed 9954, createdTime=Tue Mar 01 15:16:11 CST 2022, time=2022-03-01, status=1, ipAttribution=)]

2022-04-10 Wittyone

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：内分泌
经验分享：不错的杂志

62 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=973184, encodeId=b8739e3184bd, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：临床;内分泌 经验分享：2021-6-2号投稿 2021-6-13变成了Awaiting Decision，两周不到，这个速度是有点快，同时伴随一种不祥的预感，下周一应该能看到Decision吧，到时候再来更新，祝福我自己 --.--, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5d45263398, createdName=Q.Aur., createdTime=Sun Jun 13 00:06:23 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559798, encodeId=50cf559e9840, content=Under review 下一个是什么大概多久呀151****6521暂无昵称 2018-06-04 发表:: 投稿第二天就Under review了，听说这个杂志没有with editor这个状态151****6521暂无昵称 2018-06-04 13:56:00 发表: 投稿第二天就Under review了，听说这个杂志没有with editor这个状态, beContent=151****6521暂无昵称 2018-06-04 发表:: 投稿第二天就Under review了，听说这个杂志没有with editor这个状态, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e2398662, createdName=1234c804m77暂无昵称, createdTime=Fri Aug 03 00:00:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051656, encodeId=2a5010516561e, content=Awaiting decision一周了还没有消息，煎熬………, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200909/95b4974e88e842ffbad908960e8dd61c/ff296ee52f2547ddb4e28540d5a3eb41.jpg, createdBy=00745416786, createdName=ms1000000363315575, createdTime=Wed Sep 15 22:45:18 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115113, encodeId=ceb92115113fa, content=投稿两个多月了，现在还是Under Review，催了一次编辑说是还在找审稿人，审稿有点慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210810/2b20a1e314924e5396c0110729210109/544383ced8934545a4b92896a7ffeef1.jpg, createdBy=b6715568846, createdName=Iam雨后彩虹, createdTime=Fri Feb 17 16:10:56 CST 2023, time=2023-02-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1179873, encodeId=1f3611e9873a8, content=请问一下各位大佬，该杂志需要版面费吗，case report and review接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ca66444402, createdName=ms5000001652603950, createdTime=Sun Jan 02 22:47:21 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501260, encodeId=93da50126070, content=请问楼下的这个杂志在线投稿时，第4项是推荐reviewer，而且还是必须要填的，不然无法成功投稿，从哪里能找到他们的reviewer啊？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=440, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Feb 21 23:01:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052346, encodeId=4b6c10523465b, content=偏重的研究方向：内分泌 经验分享：2021.09.16投稿，2021.09.17让修稿，但是审稿意见就说了下如果是随机对照实验的话，请遵循对照原则（我的不是），然后提了下文章格式让弄成双倍间隔，就没有了。感觉好危险，这怎么修啊，你们的会给你发修改稿吗，上面会标注细节的那种？第一次投稿的小白，希望同道回答下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaec5572087, createdName=ms9000001057878125, createdTime=Fri Sep 17 16:29:14 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210105, encodeId=f67c12101054d, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：内分泌 经验分享：不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e29b1939503, createdName=Wittyone, createdTime=Sun Apr 10 19:28:15 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581170, encodeId=a8b45811e0f9, content=都说不收糖尿病的了hpchensd 2019-11-21 00:00:00 发表: 啥原因？我也想投一篇糖尿病高血压的, beContent=hpchensd 2019-11-21 00:00:00 发表: 啥原因？我也想投一篇糖尿病高血压的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/01/768c3273b4a500f3bc36c611fc31585d.jpg, createdBy=3f032574018, createdName=Allianst, createdTime=Mon Dec 09 00:00:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198382, encodeId=8573119838230, content=这杂志对国人友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc31688675, createdName=Labmed 9954, createdTime=Tue Mar 01 15:16:11 CST 2022, time=2022-03-01, status=1, ipAttribution=)]

2019-12-09 Allianst

都说不收糖尿病的了hpchensd 2019-11-21 00:00:00 发表:
啥原因？我也想投一篇糖尿病高血压的

hpchensd 2019-11-21 00:00:00 发表: 啥原因？我也想投一篇糖尿病高血压的

212 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=973184, encodeId=b8739e3184bd, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：临床;内分泌 经验分享：2021-6-2号投稿 2021-6-13变成了Awaiting Decision，两周不到，这个速度是有点快，同时伴随一种不祥的预感，下周一应该能看到Decision吧，到时候再来更新，祝福我自己 --.--, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5d45263398, createdName=Q.Aur., createdTime=Sun Jun 13 00:06:23 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559798, encodeId=50cf559e9840, content=Under review 下一个是什么大概多久呀151****6521暂无昵称 2018-06-04 发表:: 投稿第二天就Under review了，听说这个杂志没有with editor这个状态151****6521暂无昵称 2018-06-04 13:56:00 发表: 投稿第二天就Under review了，听说这个杂志没有with editor这个状态, beContent=151****6521暂无昵称 2018-06-04 发表:: 投稿第二天就Under review了，听说这个杂志没有with editor这个状态, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e2398662, createdName=1234c804m77暂无昵称, createdTime=Fri Aug 03 00:00:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051656, encodeId=2a5010516561e, content=Awaiting decision一周了还没有消息，煎熬………, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200909/95b4974e88e842ffbad908960e8dd61c/ff296ee52f2547ddb4e28540d5a3eb41.jpg, createdBy=00745416786, createdName=ms1000000363315575, createdTime=Wed Sep 15 22:45:18 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115113, encodeId=ceb92115113fa, content=投稿两个多月了，现在还是Under Review，催了一次编辑说是还在找审稿人，审稿有点慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210810/2b20a1e314924e5396c0110729210109/544383ced8934545a4b92896a7ffeef1.jpg, createdBy=b6715568846, createdName=Iam雨后彩虹, createdTime=Fri Feb 17 16:10:56 CST 2023, time=2023-02-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1179873, encodeId=1f3611e9873a8, content=请问一下各位大佬，该杂志需要版面费吗，case report and review接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ca66444402, createdName=ms5000001652603950, createdTime=Sun Jan 02 22:47:21 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501260, encodeId=93da50126070, content=请问楼下的这个杂志在线投稿时，第4项是推荐reviewer，而且还是必须要填的，不然无法成功投稿，从哪里能找到他们的reviewer啊？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=440, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Feb 21 23:01:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052346, encodeId=4b6c10523465b, content=偏重的研究方向：内分泌 经验分享：2021.09.16投稿，2021.09.17让修稿，但是审稿意见就说了下如果是随机对照实验的话，请遵循对照原则（我的不是），然后提了下文章格式让弄成双倍间隔，就没有了。感觉好危险，这怎么修啊，你们的会给你发修改稿吗，上面会标注细节的那种？第一次投稿的小白，希望同道回答下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaec5572087, createdName=ms9000001057878125, createdTime=Fri Sep 17 16:29:14 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210105, encodeId=f67c12101054d, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：内分泌 经验分享：不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e29b1939503, createdName=Wittyone, createdTime=Sun Apr 10 19:28:15 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581170, encodeId=a8b45811e0f9, content=都说不收糖尿病的了hpchensd 2019-11-21 00:00:00 发表: 啥原因？我也想投一篇糖尿病高血压的, beContent=hpchensd 2019-11-21 00:00:00 发表: 啥原因？我也想投一篇糖尿病高血压的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/01/768c3273b4a500f3bc36c611fc31585d.jpg, createdBy=3f032574018, createdName=Allianst, createdTime=Mon Dec 09 00:00:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198382, encodeId=8573119838230, content=这杂志对国人友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc31688675, createdName=Labmed 9954, createdTime=Tue Mar 01 15:16:11 CST 2022, time=2022-03-01, status=1, ipAttribution=)]

2022-03-01 Labmed 9954

这杂志对国人友好吗

0 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务